Abstract: The present invention relates to derivatives of succinic and glutaric acids and analogues thereof, having the following general formula: useful as inhibitors of PHEX. These derivatives are useful for promoting generation of bone mass and treating or preventing diseases or conditions associated with a phosphate metabolism defect. Methods for preparation and intermediates are also disclosed.
Type:
Grant
Filed:
May 26, 2006
Date of Patent:
April 29, 2008
Assignee:
Enobia Pharma
Inventors:
Denis Gravel, Elaref S. Ratemi, Mostafa Hatam, Guy Boileau, Philippe Crine, Isabelle Lemire
Abstract: The present invention relates to derivatives of succinic and glutaric acids and analogues thereof, having the following general formula: useful as inhibitors of PHEX. These derivatives are useful for promoting generation of bone mass and treating or preventing diseases or conditions associated with a phosphate metabolism defect. Methods for preparation and intermediates are also disclosed.
Type:
Application
Filed:
May 26, 2006
Publication date:
December 21, 2006
Applicant:
Enobia Pharma
Inventors:
Denis Gravel, Elaref Ratemi, Mostafa Hatam, Guy Boileau, Philippe Crine, Isabelle Lemire
Abstract: The present invention relates to derivatives of succinic and glutaric acids and analogues thereof, having the following general formula: useful as inhibitors of PHEX. These derivatives are useful for promoting generation of bone mass and treating or preventing diseases or conditions associated with a phosphate metabolism defect. Methods for preparation and intermediates are also disclosed.
Type:
Grant
Filed:
December 3, 2003
Date of Patent:
September 12, 2006
Assignee:
Enobia Pharma
Inventors:
Denis Gravel, Elaref S. Ratemi, Mostafa Hatam, Guy Boileau, Philippe Crine, Isabelle Lemire
Abstract: The present invention relates to derivatives of succinic and glutaric acids and analogues thereof, having the following general formula (I), useful as inhibitors of PHEX. These derivatives are useful for promoting generation of bone mass and treating or preventing diseases or conditions associated with a phosphate metabolism defect. Methods for preparation and intermediates are also disclosed.
Type:
Application
Filed:
December 3, 2003
Publication date:
June 22, 2006
Applicant:
Enobia Pharma
Inventors:
Denis Gravel, Elaref Ratemi, Mostafa Hatam, Guy Boileau, Philippe Srine, Isabelle Lemire